Eli Casdin is Director & 10% Owner at STANDARD BIOTOOLS INC. (LAB). They have made 20 open-market trades across 10 companies since 2020, most recently 2026-06-18.
CIK 0001534264
16 open-market purchases totalling $234.1M since 2020, against 4 sales. Across 16 scored buys the stock is up 5.7% at ninety days, and 0.7 points ahead of the S&P over the same stretch.
16 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 63% | 50% |
| Avg Move | +4.3% | +7.3% | +5.7% |
| Alpha | +3.2% | +4.2% | +0.7% |
| Scored | 16 | 16 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LAB | BUY | 2025-11-18 | 2025-11-20 | $1.28 | $1.4M | +11.6% | +30.2% | -11.6% |
| LAB | BUY | 2025-09-03 | 2025-09-05 | $1.28 | $638K | +0.0% | -2.2% | +6.7% |
| WGS | SELL | 2025-08-22 | 2025-08-22 | $120.90 | $60.5M | +1.9% | +1.6% | +4.9% |
| LAB | BUY | 2025-08-13 | 2025-08-15 | $1.23 | $604K | +0.0% | +7.0% | -6.3% |
| BLFS | SELL | 2025-08-11 | 2025-08-13 | $22.60 | $11.3M | +0.9% | +0.4% | +2.5% |
| BLFS | SELL | 2025-06-10 | 2025-06-12 | $23.80 | $23.8M | -4.3% | -1.4% | +18.6% |
| LAB | BUY | 2024-08-02 | 2024-08-06 | $1.62 | $1.9M | +5.0% | +16.3% | +24.6% |
| WGS | BUY | 2024-05-29 | 2024-05-31 | $21.07 | $843K | +32.7% | +39.6% | +58.1% |
| WGS | BUY | 2024-05-23 | 2024-05-28 | $20.16 | $6.7M | +14.1% | +21.5% | +62.4% |
| LAB | BUY | 2024-05-15 | 2024-05-17 | $2.56 | $4.4M | -6.4% | -22.9% | -34.2% |
| BLFS | BUY | 2023-10-19 | 2023-10-23 | $11.19 | $20.7M | +7.4% | +31.9% | +68.9% |
| LAB | BUY | 2023-05-17 | 2023-05-19 | $2.19 | $2.6M | -4.1% | -16.9% | +12.4% |
| WGS | BUY | 2023-01-31 | 2023-02-02 | $0.35 | $60.0M | -17.3% | -12.0% | -50.8% |
| SMFR | BUY | 2022-04-29 | 2022-05-03 | $4.00 | $45.8M | -10.1% | -16.2% | -26.3% |
| TNYA | BUY | 2021-08-03 | 2021-08-04 | $15.00 | $12.8M | +20.9% | +39.6% | +44.9% |
| CMLT | SELL | 2021-08-01 | 2021-08-03 | $0.00 | $0 | -0.5% | -0.1% | +0.3% |
| MXCT | BUY | 2021-07-30 | 2021-08-03 | $13.00 | $23.4M | -1.5% | +8.1% | -29.7% |
| ABSI | BUY | 2021-07-26 | 2021-07-28 | $16.00 | $25.0M | +10.0% | -20.9% | -48.4% |
| IPSC | BUY | 2021-06-22 | 2021-06-22 | $20.00 | $15.0M | +9.0% | +7.2% | -19.0% |
| GBIO | BUY | 2020-06-16 | 2020-06-18 | $19.00 | $12.3M | -2.0% | +6.8% | +39.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| WGS | 24,093 | $1.5M |
| EXAS | 8,820 | $926K |
| TNYA | 361,969 | $135K |
| TSVT | 22,625 | $113K |
| SLGC | 6,860 | $14K |
| SMFR | 12,836 | $4K |
| CMLF | 10,993,750 | — |
| SLGCW | 6,800,000 | — |
| EQRX | 8,659,372 | — |
| Total | $434.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.